|
|
In 50th Anniversary Year, Northwest Kidney Centers Gives Clyde Shields ... - MarketWatch (press release) |
|
|
Investigators at The Saban Research Institute Demonstrate That Amniotic Fluid ... - Business Wire (press release) |
Business Wire (press release)
A new study, published in the current issue of the Journal of the American Society of Nephrology, reveals that these stem cells can protect the kidneys and help maintain their function. “We believe that this novel and innovative study clearly
|
|
Novartis Blood-Pressure Drug Rasilez to Carry Warning - Wall Street Journal |
Wall Street Journal
Data suggest a risk of adverse outcomes in such patients, including hypotension, stroke and changes in renal function, including acute renal failure, the EMA said. In addition, the EMA recommended that aliskiren's prescribing label carry a warning ...
Novartis to revise product information in the European Union for high blood ... Reuters
European Medicines Agency Recommends New Contraindications and Warnings for
|
|
Investigators at The Saban Research Institute Demonstrate That Amniotic Fluid ... - EON: Enhanced Online News (press release) |
EON: Enhanced Online News (press release)
A new study, published in the current issue of the Journal of the American Society of Nephrology, reveals that these stem cells can protect the kidneys and help maintain their function. “We believe that this novel and innovative study clearly
|
|
UPDATE: Citigroup Raises PT to $89 on DaVita - Benzinga |
Benzinga
By David Johnson Citigroup raises its price target on Neutral-rated DaVita (NYSE: DVA) to $89 from $87 on on broader market valuation considerations following the company's integrated care ESRD opportunity. Citigroup says, "We believe integrated care
|
|
|
|
|
<< Start < Prev 501 502 503 504 505 506 507 508 509 510 Next > End >>
|
|
Page 507 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
